Why the study?
Pregnancy in women with pre-existing cardiomyopathy and LV systolic dysfunction or after heart transplantation carries maternal and fetal risks, but outcomes in selected patients completing pregnancy remained to be analyzed.
Pregnancy in women with pre-existing cardiomyopathy or prior heart transplantation is feasible but carries a high risk of maternal cardiovascular complications, particularly in those with cardiomyopathy.
High CV complication rates in cardiomyopathy pregnancies warrant cautious counseling; this cohort study leaves open the need for larger prospective data.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Vojtičková et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: